Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorCAMOIN, Marion
dc.contributor.authorVELHO, Gilberto
dc.contributor.authorSAULNIER, Pierre-Jean
dc.contributor.authorPOTIER, Louis
dc.contributor.authorABOULEKA, Yawa
dc.contributor.authorCARPENTIER, Charlyne
dc.contributor.authorDUBOIS, Severine
dc.contributor.authorLARROUMET, Alice
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRIGALLEAU, Vincent
IDREF: 069788146
dc.contributor.authorGAND, Elise
dc.contributor.authorBOURRON, Olivier
dc.contributor.authorBORDIER, Lyse
dc.contributor.authorSCHEEN, Andre
dc.contributor.authorHADJADJ, Samy
dc.contributor.authorROUSSEL, Ronan
dc.contributor.authorMARRE, Michel
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorMOHAMMEDI, Kamel
dc.date.accessioned2022-06-17T12:58:27Z
dc.date.available2022-06-17T12:58:27Z
dc.date.issued2022-05-09
dc.identifier.issn1475-2840 (Electronic) 1475-2840 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/140271
dc.description.abstractEnBACKGROUND: Cardiovascular disease (CVD) and nontraumatic lower-limb amputation (LLA) each results in reduced life expectancy in patients with type 1 diabetes, but the differential burden between these conditions is unknown. We compared the effects of CVD and LLA on the risk of mortality in people with type 1 diabetes. METHODS: We used pooled data from the SURGENE, GENEDIAB, and GENESIS prospective cohorts. Data were divided into: 1/absence of CVD (myocardial infarction and/or stroke) nor LLA, 2/history of CVD alone without LLA, 3/LLA alone without CVD or 4/both conditions at baseline. Participants with baseline history of peripheral artery disease were excluded from groups 1 and 2. The study endpoint was any death occurring during follow-up, regardless of the causes. RESULTS: Among 1169 participants (male 55%, age 40 ± 13 years, diabetes duration 23 ± 11 years), CVD, LLA or both were present at baseline in 49 (4.2%), 62 (5.3%) and 20 (1.7%) subjects, respectively. All-cause death occurred in 304 (26%) participants during 17-year follow-up, corresponding to 18,426 person-years and an incidence rate of 16 (95%CI, 15-18) per 1000 person-years. The risk of death increased in individuals with baseline history of CVD (adjusted HR 2.00 [95% CI 1.34-3.01], p = 0.0008) or LLA (2.26 [1.56-3.28], p < 0.0001), versus no condition, with an additive effect in people with both conditions (5.32 [3.14-9.00], p < 0.0001). No incremental risk of death was observed in people with CVD versus LLA (0.87 [0.54-1.41]). Compared with no condition, CVD and LLA were similarly associated with reduced life expectancy during follow-up: 2.79 (95% CI 1.26-4.32) and 3.38 (1.87-4.88) years, respectively. Combined conditions expose to 7.04 (4.76-9.31) less years of life expectancy (all p < 0.0001). CONCLUSIONS: CVD and LLA conferred a similar burden regarding mortality in type 1 diabetes population. Our findings encourage a careful consideration of people with type 1 diabetes and LLA as usually recommended for those with CVD, in terms of management of risk factors, treatments and prevention.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enLower-limb amputation
dc.subject.enCardiovascular disease
dc.subject.enMortality
dc.subject.enMyocardial infarction
dc.subject.enStroke
dc.subject.enType 1 diabetes mellitus
dc.title.enDifferential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s12933-022-01487-8en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35534880en_US
bordeaux.journalCardiovascular Diabetologyen_US
bordeaux.page71en_US
bordeaux.volume21en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamLEHA_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03698441
hal.version1
hal.date.transferred2022-06-17T22:22:21Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Cardiovascular%20Diabetology&amp;rft.date=2022-05-09&amp;rft.volume=21&amp;rft.issue=1&amp;rft.spage=71&amp;rft.epage=71&amp;rft.eissn=1475-2840%20(Electronic)%201475-2840%20(Linking)&amp;rft.issn=1475-2840%20(Electronic)%201475-2840%20(Linking)&amp;rft.au=CAMOIN,%20Marion&amp;VELHO,%20Gilberto&amp;SAULNIER,%20Pierre-Jean&amp;POTIER,%20Louis&amp;ABOULEKA,%20Yawa&amp;rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée